ES2192764T3 - Mimeticos de lamina beta y metodos relacionados con el uso de los mismos. - Google Patents

Mimeticos de lamina beta y metodos relacionados con el uso de los mismos.

Info

Publication number
ES2192764T3
ES2192764T3 ES98908551T ES98908551T ES2192764T3 ES 2192764 T3 ES2192764 T3 ES 2192764T3 ES 98908551 T ES98908551 T ES 98908551T ES 98908551 T ES98908551 T ES 98908551T ES 2192764 T3 ES2192764 T3 ES 2192764T3
Authority
ES
Spain
Prior art keywords
beta
same
mimetics
lamina
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98908551T
Other languages
English (en)
Spanish (es)
Inventor
Maher N Qaber
Michael K Mcmillian
Michael S Kahn
John E Tulinsky
Jessymol Mathew
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Molecumetics Ltd
Original Assignee
Molecumetics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecumetics Ltd filed Critical Molecumetics Ltd
Application granted granted Critical
Publication of ES2192764T3 publication Critical patent/ES2192764T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
ES98908551T 1998-02-12 1998-02-12 Mimeticos de lamina beta y metodos relacionados con el uso de los mismos. Expired - Lifetime ES2192764T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/002891 WO1999041276A1 (en) 1998-02-12 1998-02-12 β-SHEET MIMETICS AND METHODS RELATING TO THE USE THEREOF

Publications (1)

Publication Number Publication Date
ES2192764T3 true ES2192764T3 (es) 2003-10-16

Family

ID=22266392

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98908551T Expired - Lifetime ES2192764T3 (es) 1998-02-12 1998-02-12 Mimeticos de lamina beta y metodos relacionados con el uso de los mismos.

Country Status (9)

Country Link
EP (1) EP1053246B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002503674A (cg-RX-API-DMAC7.html)
KR (1) KR20010040939A (cg-RX-API-DMAC7.html)
AT (1) ATE230414T1 (cg-RX-API-DMAC7.html)
AU (1) AU748887B2 (cg-RX-API-DMAC7.html)
CA (1) CA2319766A1 (cg-RX-API-DMAC7.html)
DE (1) DE69810513T2 (cg-RX-API-DMAC7.html)
ES (1) ES2192764T3 (cg-RX-API-DMAC7.html)
WO (1) WO1999041276A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003525294A (ja) * 2000-02-29 2003-08-26 ブリストル−マイヤーズ スクイブ ファーマ カンパニー C型肝炎ウイルスns3プロテアーゼの阻害剤
US6534651B2 (en) 2000-04-06 2003-03-18 Inotek Pharmaceuticals Corp. 7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
US20060276497A1 (en) 2000-05-09 2006-12-07 Cephalon, Inc. Novel multicyclic compounds and the use thereof
US7122679B2 (en) 2000-05-09 2006-10-17 Cephalon, Inc. Multicyclic compounds and the use thereof
CN1642550A (zh) * 2002-02-14 2005-07-20 美瑞德生物工程公司 β-折叠模拟物和组合物及其有关方法
JP2011525927A (ja) * 2008-06-25 2011-09-29 シェーリング コーポレイション 複素環式抗菌剤の合成および使用
BR112017006920A8 (pt) 2014-10-06 2023-03-07 Quince Therapeutics Inc Inibidores de lisina gingipaína
EP3374352A4 (en) 2015-11-09 2019-10-02 Cortexyme, Inc. GINGIPAINE ARGININE INHIBITORS
PL3486242T3 (pl) 2016-08-31 2022-03-21 Jiangsu Hengrui Medicine Co. Ltd. Pochodna oksopikolinamidu, sposób jej wytwarzania i zastosowanie farmaceutyczne
MX2019003087A (es) 2016-09-16 2019-08-12 Cortexyme Inc Inhibidores cetónicos de gingipain de lisina.
EP3822264A4 (en) 2018-07-02 2021-11-10 Jiangsu Hengrui Medicine Co., Ltd. CRYSTALLINE FORMS OF AN OXYPYRIDINE AMIDE DERIVATIVE AND THEIR PREPARATION PROCESS
WO2021057818A1 (zh) 2019-09-27 2021-04-01 深圳信立泰药业股份有限公司 FXIa抑制剂及其制备方法和医药用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2117123T3 (es) * 1992-02-14 1998-08-01 Merrell Pharma Inc Derivados de aminocetilmercaptoacetilamida utilizados como inhibidores de la encefalinasa y del enzima de conversion de angiotensina.
ES2138622T3 (es) * 1992-05-15 2000-01-16 Merrell Pharma Inc Derivados de mercaptoacetilamido piridazo(1,2-a)(1,2)diazepina utilizados como inhibidores de encefalinasa y eca.
EP0618223A3 (en) * 1993-03-08 1996-06-12 Sandoz Ltd Peptides, the release of Interleukin 1-Bêta, useful as anti-inflammatory agents.
SK83897A3 (en) * 1994-12-22 1998-05-06 Iaf Biochem Int Low molecular weight bicyclic thrombin inhibitors
EP0815123B1 (en) * 1995-03-24 2001-10-04 Molecumetics, Ltd. Beta-sheet mimetics and use thereof as protease inhibitors
WO1996030396A1 (en) * 1995-03-24 1996-10-03 Molecumetics Ltd. β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
IT1277405B1 (it) * 1995-08-01 1997-11-10 Menarini Farma Ind Derivati di lattami biciclici come inibitori della trombina
WO1998005333A1 (en) * 1996-08-05 1998-02-12 Molecumetics Ltd. Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors

Also Published As

Publication number Publication date
EP1053246A1 (en) 2000-11-22
DE69810513T2 (de) 2004-03-18
AU6655798A (en) 1999-08-30
JP2002503674A (ja) 2002-02-05
CA2319766A1 (en) 1999-08-19
ATE230414T1 (de) 2003-01-15
KR20010040939A (ko) 2001-05-15
EP1053246B1 (en) 2003-01-02
DE69810513D1 (de) 2003-02-06
WO1999041276A1 (en) 1999-08-19
AU748887B2 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
NO990522D0 (no) Anvendelse av <beta>-ark mimetika som protease- og kinaseinhibatorer av transkripsjonsfaktorer
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
BR0112540A (pt) Peptìdios como inibidores da ns-3-serina protease do vìrus da hepatite c
SE9800836D0 (sv) New Compounds
ECSP055525A (es) Inhibidores de cinasas de tirosina
BRPI0616630B8 (pt) compostos de pirazol substituídos
ES2162843T3 (es) Inhibidores de la proteina quinasa c.
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
UY26092A1 (es) Uso de inhibidores de cyp2d6 en terapias de combinacion
ECSP056194A (es) Derivados de pirazolo-quinazolina, procedimiento para su preparacion y su uso como inhibidores de quinasa
BR0313733A (pt) Uso da proteìna n beta cinase
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
CY1105917T1 (el) Αναλογα ομοιου με γλυκαγονη πεπτιδιου-1
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
ES2192764T3 (es) Mimeticos de lamina beta y metodos relacionados con el uso de los mismos.
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
ATE231872T1 (de) Thiazolopyrimidinderivate
ATE432281T1 (de) Pyrrolotriazin-kinasehemmer
AR030140A1 (es) Composiciones derivadas de la 2-piridinamina y metodos relacionados
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
ECSP034530A (es) Derivados de 6-metil-tramadol sustituido en o
CY1106363T1 (el) Χρηση του ενepγοποιημενου παραγοντα πηξης vii για την αγωγη των επαγομενων απο θρομβολυτικη θepαπεια μειζονων αιμορραγιων
NO20005548D0 (no) Mykobakterieinhibitorer
MXPA05009428A (es) Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.